A paper in the inaugural issue of Microbiome describes the effort to develop and design a synthetic stool mixture to treat people with Clostridium difficile infections. Researchers led by the University of Guelph's Emma Allen-Vercoe present their therapy, which they dubbed RePOOPulate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Don't Chew The Pills!

This Week in PLOS

This Week in PNAS

What's Healthy?

Within the Soil

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.